On October 9, Hims & Hers Health Inc. rose 5.2% in regular trading, trading at $29.602/share, with Turnover of $75.7388 million.

The upward movement follows a period of market sentiment recovery as investors digest concerns surrounding a securities fraud class action lawsuit triggered by an FTC litigation disclosure. The company had previously stated that the FTC's lawsuit ignored substantial evidence submitted over a nearly three-year investigation, and it pledged to vigorously defend itself against what it called baseless allegations.

Earlier in the session, the stock had declined 5.38% amid worries about expanding litigation risk, but sentiment subsequently stabilized, driving the rebound.

Hims & Hers Health, Inc. operates a telehealth consultation platform connecting consumers to healthcare professionals for mental health, sexual health, dermatology and primary care services. The company was founded in 2017 and is headquartered in San Francisco, CA.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)